Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesAntiplatelet therapy for prevention of recurrent stroke
Current Treatment Options in Neurology, 10/29/09
Badruddin A et al. – When choosing an antiplatelet agent for this purpose, clinicians should take into account cost, side effect profile, medical comorbidity, and patient preference. To prevent recurrent stroke, aspirin alone (50–325 mg/d), a combination of aspirin (25 mg) plus extended–release dipyridamole (200 mg), given twice daily, or clopidogrel (75 mg/d) may be used as initial treatment. Prasugrel, a new thienopyridine derivative, more quickly and consistently inhibits platelets than clopidogrel. In stroke patients, prasugrel may be associated with a higher risk of brain hemorrhage, so it may not be indicated when there is a history of cerebrovascular disease.
Related Articles
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
Hypertension Research, 11/13/09
Relevance Score: 81%
Stroke-related dementia: Rates, risk factors and implications for future research
Maturitas, 11/11/09
Relevance Score: 81%
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09
Relevance Score: 81%
Ischemic stroke and hyperhomocysteinemia: truth or myth
Acta Neurologica Belgica, 10/21/09
Relevance Score: 80%
Low Ankle-Brachial Index Predicts Cardiovascular Risk After Acute Ischemic Stroke or Transient Ischemic Attack
Stroke, 10/20/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Physical Activity, Body Mass Index, and Diabetes Risk in Men: A Prospective Study
American Journal of Medicine, 12/04/09
Identification of patients at risk of ischemic events for long-term secondary prevention
Journal of the American Academy of Nurse Practitioners, 12/04/09
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
New England Journal of Medicine, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor